Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

768844

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Eyesight: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received from (a) RNIB and (b) other bodies on the time taken for access to treatment for eye care; and what steps he is taking to minimise the risk for patients experiencing irreversible sight loss due to delayed and cancelled appointments.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	107103
answer	answer is ministerial correction date of answer 16/10/2017 answer text <p>The Department has had representations from the Royal National Institute of Blind People and received letters from the Royal College of Ophthalmologists, Clinical Council for Eye Health Commissioning, All Party Parliamentary Group for Eye Health and Visual Impairment and the Chair of the Health Select Committee.</p><p> </p><p>There are currently national rules in place that should ensure if a patient’s planned follow on appointment is postponed their wait is actively monitored. In light of concerns that patients may be suffering avoidable sight loss due to delays in follow up appointments, Departmental officials are currently working with NHS England to assess the situation.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/10/2017 16:33:28 answering member 4067 label Biography information for Steve Brine
tabling member	1511 label Biography information for Lord Austin of Dudley

768845

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes: Advertising
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the advertising ban on the use of e-cigarettes.
tabling member constituency	St Albans
tabling member printed	Mrs Anne Main
uin	107087
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107152 107154 107264 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
tabling member	1568 label Biography information for Mrs Anne Main

768891

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether e-cigarettes can be promoted in public health campaigns under the Tobacco Products Directive.
tabling member constituency	St Albans
tabling member printed	Mrs Anne Main
uin	107264
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107087 107152 107154 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
tabling member	1568 label Biography information for Mrs Anne Main

768901

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes: Advertising
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make it his policy to exclude e-cigarettes from the Tobacco Products Directive ban on advertising when the UK leaves the EU.
tabling member constituency	St Albans
tabling member printed	Mrs Anne Main
uin	107152
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107087 107154 107264 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
tabling member	1568 label Biography information for Mrs Anne Main

768948

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Atrial Fibrillation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the timetable is for the NICE consultation on CG180 Atrial Fibrillation: management (2014).
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	107283
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>In September 2017, the National Institute for Health and Care Excellence (NICE) published the surveillance review decision report for the current atrial fibrillation guideline. The review confirmed that NICE would undertake a partial update of the guideline on atrial fibrillation.</p><p> </p><p>We understand that NICE intends to commission the update in early 2018, and that, once commissioned, NICE will have a better idea of the timescale, including a start date, for the update. There will be a consultation on the draft guidance but NICE cannot yet confirm a timetable. The dates for the consultation will become available on the website in due course.</p><p> </p><p>Information about the number of general practitioners (GPs) not providing anticoagulation therapy to all suitable people with atrial fibrillation is not held centrally.</p><p> </p><p>NHS England is promoting the use of GRASP-AF (Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation) within GP practices in England. GRASP-AF is an audit tool developed by and trialled in the National Health Service, which greatly simplifies the process of identifying patients with atrial fibrillation who are not receiving the right management to help reduce their risk of stroke. To support this work, an analysis of the costs and benefits of using the anticoagulant drug warfarin to help prevent stroke in people with atrial fibrillation was published in 2015.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107281 107282 question first answered 19/10/2017 14:38:39 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

768949

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Atrial Fibrillation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the number of GPs not providing anticoagulation therapy to all suitable people with atrial fibrillation; and if he will make a statement.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	107282
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>In September 2017, the National Institute for Health and Care Excellence (NICE) published the surveillance review decision report for the current atrial fibrillation guideline. The review confirmed that NICE would undertake a partial update of the guideline on atrial fibrillation.</p><p> </p><p>We understand that NICE intends to commission the update in early 2018, and that, once commissioned, NICE will have a better idea of the timescale, including a start date, for the update. There will be a consultation on the draft guidance but NICE cannot yet confirm a timetable. The dates for the consultation will become available on the website in due course.</p><p> </p><p>Information about the number of general practitioners (GPs) not providing anticoagulation therapy to all suitable people with atrial fibrillation is not held centrally.</p><p> </p><p>NHS England is promoting the use of GRASP-AF (Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation) within GP practices in England. GRASP-AF is an audit tool developed by and trialled in the National Health Service, which greatly simplifies the process of identifying patients with atrial fibrillation who are not receiving the right management to help reduce their risk of stroke. To support this work, an analysis of the costs and benefits of using the anticoagulant drug warfarin to help prevent stroke in people with atrial fibrillation was published in 2015.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107281 107283 question first answered 19/10/2017 14:38:39 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

768950

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Atrial Fibrillation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that people diagnosed with atrial fibrillation (AF) receive therapy to prevent AF-related stroke.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	107281
answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>In September 2017, the National Institute for Health and Care Excellence (NICE) published the surveillance review decision report for the current atrial fibrillation guideline. The review confirmed that NICE would undertake a partial update of the guideline on atrial fibrillation.</p><p> </p><p>We understand that NICE intends to commission the update in early 2018, and that, once commissioned, NICE will have a better idea of the timescale, including a start date, for the update. There will be a consultation on the draft guidance but NICE cannot yet confirm a timetable. The dates for the consultation will become available on the website in due course.</p><p> </p><p>Information about the number of general practitioners (GPs) not providing anticoagulation therapy to all suitable people with atrial fibrillation is not held centrally.</p><p> </p><p>NHS England is promoting the use of GRASP-AF (Guidance on Risk Assessment and Stroke Prevention for Atrial Fibrillation) within GP practices in England. GRASP-AF is an audit tool developed by and trialled in the National Health Service, which greatly simplifies the process of identifying patients with atrial fibrillation who are not receiving the right management to help reduce their risk of stroke. To support this work, an analysis of the costs and benefits of using the anticoagulant drug warfarin to help prevent stroke in people with atrial fibrillation was published in 2015.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107282 107283 question first answered 19/10/2017 14:38:39 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

768953

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tuberculosis: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to make the Bacillus Calmette-Guérin vaccination available on the NHS to all babies and children under the age of 16.
tabling member constituency	South Thanet
tabling member printed	Craig Mackinlay
uin	107270
answer	answer is ministerial correction date of answer 16/10/2017 answer text <p>The Bacillus Calmette-Guérin (BCG) immunisation programme is a risk-based programme, with the key component being the neonatal programme which targets those most at risk from or exposure to tuberculosis. The BCG vaccine is also offered to at risk individuals under the age of 16. There are no plans to extend this further.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/10/2017 16:42:36 answering member 4067 label Biography information for Steve Brine
tabling member	4529 label Biography information for Craig Mackinlay

768955

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will establish an independent taskforce for lung health.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	107275
answer	answer is ministerial correction date of answer 16/10/2017 answer text <p>There are currently no plans to set up a taskforce on lung health. However, the Government’s Mandate to <a href="https://en.wikipedia.org/wiki/NHS_England" target="_blank">NHS England</a> includes a requirement to achieve a significant reduction in avoidable deaths by 2020. Reducing premature mortality rates among patients with lung disease will play an important part in this. There are a range of initiatives being taken forward that will support reducing mortality rates amongst patients with lung disease.</p><p> </p><p>NHS England advises that the National Institute for Health and Care Excellence is currently producing new guidelines on asthma and Chronic Obstructive Pulmonary Disease (COPD) and the ongoing National Audit on COPD will be joined by one on asthma next year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/10/2017 16:21:02 answering member 4067 label Biography information for Steve Brine
tabling member	298 label Biography information for Steve McCabe

768956

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to assess the effect on improving the treatment of diabetes of the transformation funding for diabetes services; and if he will make a statement.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	107308
answer	answer is ministerial correction date of answer 16/10/2017 answer text <p>NHS England is developing a diabetes transformation dashboard which will be used to monitor outcomes of the allocations made through the transformation funding. The diabetes transformation dashboard will pull together data from a number of sources to enable short-term indicators of effectiveness, as well as long-term outcomes to be monitored.</p><p> </p><p>NHS England developed a Best Possible Value framework to inform the allocation of funding to clinical commissioning groups and Sustainability and Transformation Partnerships. This approach aimed to place consideration of value to populations, to patients and to taxpayers at the heart of decision-making. It aimed to identify where the potential for improvement was greatest. The approach to allocation of funding also included consideration of existing inequalities in service provision.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107307 question first answered 16/10/2017 16:44:15 answering member 4067 label Biography information for Steve Brine
tabling member	163 label Biography information for Sir Stephen Timms